Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (167)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Clark, A. M.
Right arrow Articles by Norman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, A. M.
Right arrow Articles by Norman, R. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 13, 1502-1505, Copyright © 1998 by Oxford University Press


ARTICLES

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

AM Clark, B Thornley, L Tomlinson, C Galletley and RJ Norman
Department of Obstetrics and Gynaecology, The Queen Elizabeth Hospital, University of Adelaide, Woodville, SA, Australia.

Obesity affects ovulation, response to fertility treatment, pregnancy rates and outcome. In this prospective study, a weight loss programme was assessed to determine whether it could help obese infertile women, irrespective of their infertility diagnosis, to achieve a viable pregnancy, ideally without further medical intervention. The subjects underwent a weekly programme aimed at lifestyle changes in relation to exercise and diet for 6 months; those that did not complete the 6 months were treated as a comparison group. Women in the study lost an average of 10.2 kg/m2, with 60 of the 67 anovulatory subjects resuming spontaneous ovulation, 52 achieving a pregnancy (18 spontaneously) and 45 a live birth. The miscarriage rate was 18%, compared to 75% for the same women prior to the programme. Psychometric measurements also improved. None of these changes occurred in the comparison group. The cost savings of the programme were considerable. Prior to the programme, the 67 women had had treatment costing a total of A$550,000 for two live births, a cost of A$275,000 per baby. After the programme, the same women had treatment costing a total of A$210,000 for 45 babies, a cost of A$4600 per baby. Thus weight loss should be considered as a first option for women who are infertile and overweight.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
D. A. Van Vugt
Brain imaging studies of appetite in the context of obesity and the menstrual cycle
Hum. Reprod. Update, November 19, 2009; (2009) dmp051v1.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Vahratian and Y. R. Smith
Should access to fertility-related services be conditional on body mass index?
Hum. Reprod., July 1, 2009; 24(7): 1532 - 1537.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
K. Hammerli, H. Znoj, and J. Barth
The efficacy of psychological interventions for infertile patients: a meta-analysis examining mental health and pregnancy rate
Hum. Reprod. Update, May 1, 2009; 15(3): 279 - 295.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Metwally, S. Amer, T.C. Li, and W.L. Ledger
An RCT of metformin versus orlistat for the management of obese anovulatory women
Hum. Reprod., April 1, 2009; 24(4): 966 - 975.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. L. Steckler, C. Herkimer, D. A. Dumesic, and V. Padmanabhan
Developmental Programming: Excess Weight Gain Amplifies the Effects of Prenatal Testosterone Excess On Reproductive Cyclicity--Implication for Polycystic Ovary Syndrome
Endocrinology, March 1, 2009; 150(3): 1456 - 1465.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Maheshwari, G. Scotland, J. Bell, A. McTavish, M. Hamilton, and S. Bhattacharya
The direct health services costs of providing assisted reproduction services in overweight or obese women: a retrospective cross-sectional analysis
Hum. Reprod., March 1, 2009; 24(3): 633 - 639.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
A.E. Nieuwenhuis-Ruifrok, W.K.H. Kuchenbecker, A. Hoek, P. Middleton, and R.J. Norman
Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis
Hum. Reprod. Update, January 1, 2009; 15(1): 57 - 68.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Koivunen, A. Pouta, S. Franks, H. Martikainen, U. Sovio, A-L. Hartikainen, M.I. McCarthy, A. Ruokonen, A. Bloigu, M-R. Jarvelin, et al.
Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
Hum. Reprod., September 1, 2008; 23(9): 2134 - 2139.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. Franks, J. Stark, and K. Hardy
Follicle dynamics and anovulation in polycystic ovary syndrome
Hum. Reprod. Update, May 22, 2008; (2008) dmn015v1.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Z. Veleva, A. Tiitinen, S. Vilska, C. Hyden-Granskog, C. Tomas, H. Martikainen, and J. S. Tapanainen
High and low BMI increase the risk of miscarriage after IVF/ICSI and FET
Hum. Reprod., April 1, 2008; 23(4): 878 - 884.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Palomba, F. Giallauria, A. Falbo, T. Russo, R. Oppedisano, A. Tolino, A. Colao, C. Vigorito, F. Zullo, and F. Orio
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study
Hum. Reprod., March 1, 2008; 23(3): 642 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. O. Yildiz, E. S. Knochenhauer, and R. Azziz
Impact of Obesity on the Risk for Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 162 - 168.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. J. Moran, M. Noakes, P. M. Clifton, and R. J. Norman
The Use of Anti-Mullerian Hormone in Predicting Menstrual Response after Weight Loss in Overweight Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3796 - 3802.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. L. Barbieri
Clomiphene Versus Metformin for Ovulation Induction in Polycystic Ovary Syndrome: The Winner Is ....
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3399 - 3401.
[Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
A. Maheshwari, L. Stofberg, and S. Bhattacharya
Effect of overweight and obesity on assisted reproductive technology a systematic review
Hum. Reprod. Update, September 1, 2007; 13(5): 433 - 444.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. Panidis, D. Farmakiotis, D. S.H. Bell, T. Geberhiwot, A. F. Jones, R. S. Legro, and E. R. Myers
Treatment of Infertility in the Polycystic Ovary Syndrome
N. Engl. J. Med., May 10, 2007; 356(19): 1999 - 2001.
[Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
G.F. Homan, M. Davies, and R. Norman
The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: a review
Hum. Reprod. Update, May 1, 2007; 13(3): 209 - 223.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. M. Nelson and R. F. Fleming
The preconceptual contraception paradigm: obesity and infertility
Hum. Reprod., April 1, 2007; 22(4): 912 - 915.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D.C. Gesink Law, R.F. Maclehose, and M.P. Longnecker
Obesity and time to pregnancy
Hum. Reprod., February 1, 2007; 22(2): 414 - 420.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Jauniaux, R. G. Farquharson, O. B. Christiansen, N. Exalto, and On behalf of ESHRE Special Interest Group for Earl
Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage
Hum. Reprod., September 1, 2006; 21(9): 2216 - 2222.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Lubin, A. Chetrit, B. Modan, and L. S. Freedman
Dietary Intake Changes and Their Association with Ovarian Cancer Risk
J. Nutr., September 1, 2006; 136(9): 2362 - 2367.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. J Moran, M. Noakes, P. M Clifton, G. A Wittert, G. Williams, and R. J Norman
Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome
Am. J. Clinical Nutrition, July 1, 2006; 84(1): 77 - 87.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Tang, J. Glanville, N. Orsi, J. H. Barth, and A. H. Balen
The use of metformin for women with PCOS undergoing IVF treatment
Hum. Reprod., June 1, 2006; 21(6): 1416 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Tang, J. Glanville, C. J. Hayden, D. White, J. H. Barth, and A. H. Balen
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study
Hum. Reprod., January 1, 2006; 21(1): 80 - 89.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. E. Messinis
Ovulation induction: a mini review
Hum. Reprod., October 1, 2005; 20(10): 2688 - 2697.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Second World Congress on the Insulin Resistance Syndrome: Mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy
Diabetes Care, July 1, 2005; 28(7): 1821 - 1830.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Palomba, F. Orio Jr., A. Falbo, F. Manguso, T. Russo, T. Cascella, A. Tolino, E. Carmina, A. Colao, and F. Zullo
Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4068 - 4074.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T.M. de Liz and B. Strauss
Differential efficacy of group and individual/couple psychotherapy with infertile patients
Hum. Reprod., May 1, 2005; 20(5): 1324 - 1332.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Jayagopal, E. S. Kilpatrick, S. Holding, P. E. Jennings, and S. L. Atkin
Orlistat Is as Beneficial as Metformin in the Treatment of Polycystic Ovarian Syndrome
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 729 - 733.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Fedorcsak, P. O. Dale, R. Storeng, G. Ertzeid, S. Bjercke, N. Oldereid, A. K. Omland, T. Abyholm, and T. Tanbo
Impact of overweight and underweight on assisted reproduction treatment
Hum. Reprod., November 1, 2004; 19(11): 2523 - 2528.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. J. Norman
Metformin--Comparison with Other Therapies in Ovulation Induction in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4797 - 4800.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Palomba, F. Orio Jr., L. G. Nardo, A. Falbo, T. Russo, D. Corea, P. Doldo, G. Lombardi, A. Tolino, A. Colao, et al.
Metformin Administration Versus Laparoscopic Ovarian Diathermy in Clomiphene Citrate-Resistant Women with Polycystic Ovary Syndrome: A Prospective Parallel Randomized Double-Blind Placebo-Controlled Trial
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4801 - 4809.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. J. Moran, M. Noakes, P. M. Clifton, G. A. Wittert, L. Tomlinson, C. Galletly, N. D. Luscombe, and R. J. Norman
Ghrelin and Measures of Satiety Are Altered in Polycystic Ovary Syndrome But Not Differentially Affected by Diet Composition
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3337 - 3344.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
R. J. Norman, M. Noakes, R. Wu, M. J. Davies, L. Moran, and J. X. Wang
Improving reproductive performance in overweight/obese women with effective weight management
Hum. Reprod. Update, May 1, 2004; 10(3): 267 - 280.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. M Lord, I. H K Flight, and R. J Norman
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
BMJ, October 25, 2003; 327(7421): 951.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Harborne, R. Fleming, H. Lyall, N. Sattar, and J. Norman
Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4116 - 4123.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. G. Crosignani, M. Colombo, W. Vegetti, E. Somigliana, A. Gessati, and G. Ragni
Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet
Hum. Reprod., September 1, 2003; 18(9): 1928 - 1932.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. J. Moran, M. Noakes, P. M. Clifton, L. Tomlinson, and R. J. Norman
Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
F. Lubin, A. Chetrit, L. S. Freedman, E. Alfandary, Y. Fishler, H. Nitzan, A. Zultan, and B. Modan
Body Mass Index at Age 18 Years and during Adult Life and Ovarian Cancer Risk
Am. J. Epidemiol., January 15, 2003; 157(2): 113 - 120.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Fleming, Z. E. Hopkinson, A. M. Wallace, I. A. Greer, and N. Sattar
Ovarian Function and Metabolic Factors in Women with Oligomenorrhea Treated with Metformin in a Randomized Double Blind Placebo-Controlled Trial
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 569 - 574.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Fedorcsak, P. O. Dale, R. Storeng, T. Tanbo, and T. Abyholm
The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome
Hum. Reprod., June 1, 2001; 16(6): 1086 - 1091.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M.-M. Huber-Buchholz, D. G. P. Carey, and R. J. Norman
Restoration of Reproductive Potential by Lifestyle Modification in Obese Polycystic Ovary Syndrome: Role of Insulin Sensitivity and Luteinizing Hormone
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1470 - 1474.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
H. Lashen, W. Ledger, A. L. Bernal, and D. Barlow
Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization
Hum. Reprod., March 1, 1999; 14(3): 712 - 715.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.